Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Sutter

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
The Journal of General Virology|August 20, 2010
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret modelJoost H C M Kreijtz, Yasemin Süzer, Rogier Bodewes, et al.
The Journal of Infectious Diseases|March 1, 2023
Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike ProteinMatthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Iscience|August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approachLeonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Emerging Infectious Diseases|June 21, 2021
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement HomeClaudia Schulz, Claudia Wylezich, Kerstin Wernike, et al.
Science (New York, N.Y.)|December 19, 2015
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camelsBart L Haagmans, Judith M A van den Brand, V Stalin Raj, et al.
Journal of Virology|December 3, 2003
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239Thorsten U Vogel, Matthew R Reynolds, Deborah H Fuller, et al.
Journal of Virology|June 20, 2002
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239Helen Horton, Thorsten U Vogel, Donald K Carter, et al.
Immunity|February 14, 2016
In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell CooperativityStephan Halle, Kirsten Anja Keyser, Felix Rolf Stahl, et al.
Nature Communications|August 8, 2024
Multi-omics characterization of the monkeypox virus infectionYiqi Huang, Valter Bergant, Vincent Grass, et al.
The Journal of Infectious Diseases|June 19, 2018
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical TrialRory D de Vries, Arwen F Altenburg, Nella J Nieuwkoop, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
The Journal of General Virology|August 20, 2010
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret modelJoost H C M Kreijtz, Yasemin Süzer, Rogier Bodewes, et al.
The Journal of Infectious Diseases|March 1, 2023
Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike ProteinMatthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Iscience|August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approachLeonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Emerging Infectious Diseases|June 21, 2021
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement HomeClaudia Schulz, Claudia Wylezich, Kerstin Wernike, et al.
Science (New York, N.Y.)|December 19, 2015
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camelsBart L Haagmans, Judith M A van den Brand, V Stalin Raj, et al.
Journal of Virology|December 3, 2003
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239Thorsten U Vogel, Matthew R Reynolds, Deborah H Fuller, et al.
Journal of Virology|June 20, 2002
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239Helen Horton, Thorsten U Vogel, Donald K Carter, et al.
Immunity|February 14, 2016
In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell CooperativityStephan Halle, Kirsten Anja Keyser, Felix Rolf Stahl, et al.
Nature Communications|August 8, 2024
Multi-omics characterization of the monkeypox virus infectionYiqi Huang, Valter Bergant, Vincent Grass, et al.
The Journal of Infectious Diseases|June 19, 2018
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical TrialRory D de Vries, Arwen F Altenburg, Nella J Nieuwkoop, et al.
Pageof 18